Zeineddin Ahmad, Cornwell Edward E, Fullum Terrence M, Chu Quyen D, Kearse LaDonna, Ayad Marco H, Li Sandy, Williams Mallory
From the Department of Surgery, Howard University College of Medicine, Washington, DC (Zeineddin, Cornwell III, Fullum, Chu, Ayad, Li, Williams).
Clive O Callender Surgery Outcomes Center, Howard University, Washington, DC (Zeineddin, Cornwell III, Fullum, Chu, Williams).
J Am Coll Surg. 2024 Apr 1;238(4):543-550. doi: 10.1097/XCS.0000000000000949. Epub 2024 Mar 15.
Up to 85% of patients with sickle cell disease (SCD) will develop gallstones by their third decade. Cholecystectomy is the most commonly performed procedure in these patients. Cholecystectomy is recommended for patients with SCD with symptomatic cholelithiasis and leads to lower morbidity. No contemporary large studies have evaluated this recommendation or associated clinical outcomes. This study evaluates clinical outcomes after cholecystectomy in patients with SCD and cholelithiasis with specific advanced clinical presentations.
The Nationwide Inpatient Sample was queried for patients with SCD and gallbladder disease between 2006 and 2015. Patients were divided into groups based on their disease presentation, including uncomplicated cholelithiasis, acute and chronic cholecystitis, and gallstone pancreatitis. Clinical outcomes associated with disease presentation were analyzed. Statistical analysis was performed using the Student's t -test, chi-square test, ANOVA, and logistic regression.
There were 6,662 patients with SCD who presented with cholelithiasis. Median age was 20 (interquartile range 16 to 34) years and 54% were female patients. Cholecystectomy was performed in 1,779 patients with SCD with the most common indication being chronic cholecystitis (44%), followed by uncomplicated cholelithiasis (27%), acute cholecystitis (21%), and choledocholithiasis or gallstone pancreatitis (8%). On multivariable regression, advanced clinical presentation was the strongest predictor of perioperative vaso-occlusive crisis, which was the most common complication. Patients undergoing cholecystectomy for uncomplicated cholelithiasis were at lower risk than those with acute cholecystitis (odds ratio [OR] 2.37; 95% CI 1.64 to 3.41), chronic cholecystitis (OR 1.74; 95% CI 1.26 to 2.4), and choledocholithiasis or gallstone pancreatitis (OR 2.24; 95% CI 1.41 to 3.57).
Seventy-three percent of patients with SCD have advanced clinical presentation at the time of their cholecystectomy. After cholecystectomy, perioperative vaso-occlusive events were significantly increased in patients with advanced clinical presentation. These data support screening abdominal ultrasounds and early cholecystectomy for cholelithiasis in patients with SCD.
高达85%的镰状细胞病(SCD)患者在30岁前会患上胆结石。胆囊切除术是这些患者最常进行的手术。对于有症状性胆石症的SCD患者,建议进行胆囊切除术,这可降低发病率。目前尚无当代大型研究评估这一建议或相关临床结果。本研究评估了有特定晚期临床表现的SCD合并胆石症患者胆囊切除术后的临床结果。
查询2006年至2015年间全国住院患者样本中患有SCD和胆囊疾病的患者。根据疾病表现将患者分为几组,包括单纯性胆石症、急性和慢性胆囊炎以及胆石性胰腺炎。分析与疾病表现相关的临床结果。使用学生t检验、卡方检验、方差分析和逻辑回归进行统计分析。
有6662例患有胆石症的SCD患者。中位年龄为20岁(四分位间距16至34岁),54%为女性患者。1779例SCD患者接受了胆囊切除术,最常见的适应证是慢性胆囊炎(44%),其次是单纯性胆石症(27%)、急性胆囊炎(21%)以及胆总管结石或胆石性胰腺炎(8%)。在多变量回归分析中,晚期临床表现是围手术期血管闭塞性危机的最强预测因素,而围手术期血管闭塞性危机是最常见的并发症。因单纯性胆石症接受胆囊切除术的患者比急性胆囊炎患者风险更低(比值比[OR]2.37;95%可信区间1.64至3.41),比慢性胆囊炎患者风险更低(OR 1.74;95%可信区间1.26至2.4),比胆总管结石或胆石性胰腺炎患者风险更低(OR 2.24;95%可信区间1.41至3.57)。
73%的SCD患者在进行胆囊切除术时具有晚期临床表现。胆囊切除术后,晚期临床表现患者的围手术期血管闭塞事件显著增加。这些数据支持对SCD患者进行腹部超声筛查并对胆石症进行早期胆囊切除术。